Wei Cui
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Renal and related cancers
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
- Oncology 25
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 5
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
Wei Cui
84 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 429
- Molecular Biology 1.0k
- Oncology 398
- Hematology 127
- Rheumatology 144
Countries citing papers authored by Wei Cui
This map shows the geographic impact of Wei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cui more than expected).
Fields of papers citing papers by Wei Cui
This network shows the impact of papers produced by Wei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cui. The network helps show where Wei Cui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 4 | |
| 8 | Epidemiological and clinical findings of discharge patients infected with the 2019 novel coronavirus (SARS-COV-2) in Changchun, Northeast China: A retrospective cohort study | 2021 | 2 |
| 9 | 2020 | 20 | |
| 10 | 2020 | 13 | |
| 11 | 2019 | 57 | |
| 12 | 2016 | 27 | |
| 13 | 2014 | 10 | |
| 14 | 2013 | 16 | |
| 15 | 2012 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2011 | 53 | |
| 18 | 2011 | 14 | |
| 19 | 2010 | 10 | |
| 20 | 2006 | 170 |
About Wei Cui
Wei Cui is a scholar working on Oncology, Cancer Research, Genetics, Hepatology and Physiology, having authored 88 papers that have together received 1.8k indexed citations. Recurring topics across this work include Renal and related cancers (11 papers), RNA modifications and cancer (10 papers), Clinical Laboratory Practices and Quality Control (7 papers), Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (429 citations), Molecular Biology (1.0k citations), Oncology (398 citations), Hematology (127 citations) and Rheumatology (144 citations). Wei Cui has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Donghong Zhang, Ye Guo, Yuqing Pei, Danfei Xu, Li Chai, Wei Wu, Raymond Lai, Yupo Ma, Fei Wang and Xiaoying Lou. Their work appears in journals such as Clinica Chimica Acta, Blood, Scientific Reports, Scandinavian Journal of Clinical and Laboratory Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.